News

Virbac : Declaration of the number of shares and voting rights 06/2023

              DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS       Information…

1 year ago

Viracta Therapeutics to Host R&D Day on October 4, 2023

SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on…

1 year ago

Immutep to Participate in September Investor Conferences

SYDNEY, AUSTRALIA, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage…

1 year ago

Folia Health Reinforces Commitment to Autoimmune and Neurological Conditions: Announcing the Expansion of Multiple Sclerosis, Huntington’s Disease, and Myasthenia Gravis User Cohorts

Folia Health Announces Expansion of HD, MS, MG cohorts By expanding their patient and caregiver user cohorts living with these…

1 year ago

Artelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 13th

SOLANA BEACH, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on…

1 year ago

Solera Introduces Weight Loss Solution to Help Payers and Employers Manage Skyrocketing GLP-1 Demand While Empowering Individuals to Make Informed Choices

GLP-1 Support from Solera can save tens of millions by streamlining step therapy and the prior authorization process for health…

1 year ago

Solid Biosciences to Participate at Upcoming Investor Conferences

CHARLESTOWN, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for…

1 year ago

Virbac : Declaration of the number of shares and voting rights 05/2023

              DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS       Information…

1 year ago

Virbac : Declaration of the number of shares and voting rights 04/2023

              DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS       Information…

1 year ago

Avenue Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference

MIAMI, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company…

1 year ago